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Ambient air pollution has been associated
with a multitude of health effects, including
mortality, respiratory and cardiovascular
hospitalizations, changes in lung function,
asthma attacks, and days lost from work
(Bates 1995a; Pope 1996, 2000; Samet et al.
2000a, 2000b; Segala 1999). These studies
have been performed in multiple cities around
the United States and internationally using
various designs and statistical methods.
Attempts have been made to consider
the public health impacts of the criteria air
pollutants [particulate matter (PM), ozone,
carbon monoxide, sulfur dioxide, nitrogen
dioxide, and lead]. The U.S. Clean Air Act
(CAA) Amendments of 1990 (1990) included
the provision (section 812) that the U.S.
Environmental Protection Agency (U.S. EPA)
perform periodic analyses of the beneﬁts and
costs of the CAA. A retrospective analysis of
the benefits and costs from 1970 to 1990
compared the costs of implementation of the
CAA and its regulations with the health and
welfare effects avoided (benefits) because of
decreases in criteria air pollutant concentra-
tions and found that benefits outweighed
costs between 11 and 95 times (U.S. EPA
1997). A prospective analysis examining the
benefits and costs of criteria air pollutant
reductions (excluding lead) from 1990 to
2010 found that benefits would outweigh
costs by 4 to 1 in 2010 (U.S. EPA 1999a).
In retrospective and prospective analyses, the
U.S. EPA attempted to analyze the effects
of the criteria air pollutants on 20 health end
points. Although some children’s health
effects were considered, these data were not
comprehensive and were typically aggregated
with estimates of impacts in adults. Lave and
Seskin (1970) included infant mortality rates
in their analysis of mortality attributable to
air pollution in the 1960s. International and
regional analyses have also been recently
conducted but do not highlight child-speciﬁc
impacts (Cifuentes et al. 2001; Hall et al.
1992; Murray and Lopez 1997).
In the United States, federal impetus has
increased to include benefit–cost analyses
when promulgating signiﬁcant pieces of regu-
lation (> $100 million), or beneﬁt–cost analy-
ses may be included in new or amended
legislation. Executive Order 12866 of 1993
(Clinton 1993) established principles for eval-
uating risks, beneﬁts, and costs of proposed,
existing, or final pieces of significant regula-
tion. Similarly, U.S. Executive Order 13045
(Clinton 1997) has led to increased federal
attention to the speciﬁc susceptibility of chil-
dren. Regulatory analyses can be useful tools
and provide valuable information for decision
makers (National Research Council 2002).
Several studies examining the associations
between ambient air pollution and health
effects have focused exclusively on the health
effects of infants and children. This focus is
important because children may be at higher
risk than adults due to several factors, includ-
ing differences in exposures, differences in
age-speciﬁc activity patterns, and varying sen-
sitivity during specific periods of develop-
ment. Estimates based on U.S. surveillance
data indicate that in 1999 asthma accounted
for 658,000 emergency department visits,
with children < 5 years old having the highest
hospitalization and emergency department
visit rates (Centers for Disease Control and
Prevention 2002). Speciﬁc to children, associ-
ations with air pollution have been found for
hospitalizations, increased symptoms,
decreased lung function, low birth weight
(LBW), and school absences (Bates 1995b).
Associations with postneonatal mortality have
been found for ambient pollution levels in
the United States (Woodruff et al. 1997).
Recent studies in the United States and inter-
nationally have found impacts on intrauterine
death, birth outcomes, LBW, birth defects,
and premature delivery (Bobak 2000; Bobak
and Leon 1992; Bobak et al. 1999, 2001;
Dejmek et al. 1999; Maisonet et al. 2000;
Ritz and Yu 1999; Ritz et al. 2000, 2002;
Rogers et al. 2000).
In this article, we expand an existing
benefit–cost analysis framework to examine
the impacts of the criteria air pollutants
except lead on children’s health and to quan-
tify the health beneﬁts associated with reduc-
tions in criteria air pollutants during the
period 1990–2010. The U.S. EPA prospec-
tive (1990–2010) analysis has previously con-
sidered the following health end points
specifically for children: postneonatal infant
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Beneﬁt–cost analyses of environmental regulations are increasingly mandated in the United States.
Evaluations of criteria air pollutants have focused on benefits and costs associated with adverse
health effects. Children are signiﬁcantly affected by the health beneﬁts of improved air quality, yet
key environmental health policy analyses have not previously focused specifically on children’s
effects. In this article we present a “meta-analysis” approach to child-specific health impacts
derived from the U.S. Clean Air Act (CAA). On the basis of data from existing studies, reductions
in criteria air pollutants predicted to occur by 2010 because of CAA regulations are estimated to
produce the following impacts: 200 fewer expected cases of postneonatal mortality; 10,000 fewer
asthma hospitalizations in children 1–16 years old, with estimated beneﬁts ranging from $20 mil-
lion to $46 million (1990 U.S.$); 40,000 fewer emergency department visits in children 1–16
years old, with estimated benefits ranging from $1.3 million to $5.8 million; 20 million school
absences avoided by children 6–11 years old, with estimated benefits of $0.7–1.8 billion; and
10,000 fewer infants of low birth weight, with estimated benefits of $230 million. Inclusion of
limited child-speciﬁc data on hospitalizations, emergency department visits, school absences, and
low birth weight could be expected to add $1–2 billion (1990 US$) to the $8 billion in health
beneﬁts currently estimated to result from decreased morbidity, and $600 million to the $100 bil-
lion estimated to result from decreased mortality. These estimates highlight the need for increased
consideration of children’s health effects. Key needs for environmental health policy analyses
include improved information for children’s health effects, additional life-stage–speciﬁc informa-
tion, and improved health economics information speciﬁc for children. Key words: air pollution,
benefit, children, morbidity, mortality, risk assessment. Environ Health Perspect 112:226–232
(2004). doi:10.1289/ehp.6299 available via http://dx.doi.org/ [Online 14 October 2003]mortality (not included in the U.S. EPA’s
main results); asthma hospitalizations; emer-
gency department visits for asthma; acute
bronchitis; upper and lower respiratory symp-
toms; and respiratory illnesses (U.S. EPA
1999a). We therefore performed our study to
identify child-specific health end points that
were not included in the prospective analysis,
to update the literature where available, to
estimate the national health impacts for chil-
dren of reductions in the criteria air pollu-
tants, and to conduct a preliminary estimation
of the associated benefits. We used a model
that was developed previously to follow
the methodology of the U.S. EPA (1999a)
while also considering inter- and intrastudy
uncertainty, transparency, and best practice
(Farrow et al. 2001). This model has been
previously calibrated to and shown to approx-
imate the U.S. EPA 1990–2010 analysis
(Farrow et al. 2001).
Materials and Methods
To examine impacts of the criteria air pollu-
tants on children, we surveyed the peer-
reviewed air pollution literature (last search
conducted April 2002) for studies focused
exclusively on children or presenting results
for children ≤ 18 years of age in the United
States, and the impacts of one of the follow-
ing: PM ≤ 10 µm and ≤ 2.5 µm in diameter
(PM10, PM2.5), O3, CO, NO2, or SO2. The
effects of lead were not included because of
low ambient concentrations during the time
period 1990–2010. The methodology evolved
from the U.S. EPA (1999a) and is briefly
described below. More detail is presented in
Farrow et al. (2001). A literature search was
performed in Medline (National Library of
Medicine 2002) using the key words “child”
(and all variants) and the pollutants of interest
for studies examining the epidemiology-based
exposure–response relationship between
outdoor criteria air pollutant concentrations
and children’s health effects. All available
studies were used in the analysis below except
that of Rogers et al. (2000), which used an
unusual exposure metric (total suspsended
particulates + SO2). An important aspect of
this meta-analysis type approach is the incor-
poration of exposure–response parameters
and value estimates from multiple sources
where possible. We modified results from
published studies very little because our
explicit intent was to capture the original
authors’ modeling and characterization.
Information was extracted from each study on
the study population and location, pollutants
studied, exposure levels, statistical methods,
exposure–response function used, lag struc-
ture, International Classification of Diseases,
9th revision, codes (U.S. Department of
Health and Human Services 1991) or symp-
toms deﬁning a case (if applicable), exposure–
response parameter (β coefficient, relative
risk, or percent change), and measure of error
[standard error (SE) or confidence interval
(CI)].
We included 23 original studies examining
the association between a considered health
effect and an air pollutant (Tables 1–3). In
Table 1, health studies examining mortality
and hospitalization outcomes are listed
by health effect and pollutant considered.
Table 1 includes, for each study, summary
information on key parameters and ﬁndings:
the regression coefficient and SE describing
the exposure–response relationship, exposure
measure, and geographic locale considered.
One Canadian study was also included
because of geographic proximity and demo-
graphic similarity. Table 2 lists parameters
and findings for respiratory ailments not
requiring hospitalization. Table 3 details risk
information for previously unconsidered
child-speciﬁc health end points. All informa-
tion presented in the tables was used in the
analysis. Multiple values per pollutant pre-
sented for a single study may denote either
differences in exposure measures or data
sources. Data entry was validated through
replication by a second member and quality
assurance/quality control analysis by a third
member of the group.
To estimate the expected cases averted for
each health effect considered, we converted
measures of risk to an exposure–response
regression coefficient. Because most regres-
sions were in a log-linear form, the term
“regression coefficient” is used here and
describes the general case. Regression coeffi-
cients reported in the study were used
untransformed. Measures of risk reported as
odds ratios or percent change were converted
into a regression coefficient using the prop-
erty that the natural logarithm of the odds
ratio is the regression coefficient. For each
study, the central tendency and variation of
the exposure–response parameter were used.
Study-specific exposure–response functions
were used. Log-linear models were used by
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Table 1. Data from studies analyzing children’s health, mortality, and hospitalizations (ages denote those examined in the present study).
End points Age (years) Reference Pollutant Location, year Risk coefﬁcient (SE) Exposure measure
Postneonatal mortality 1 month–1 year Woodruff et al. 1997 PM10 Various U.S. cities, 1989–1991 0.00392 (0.0012) µg/m3 Mean PM10 for ﬁrst
2 months of life
Hospital admissions < 2, < 5 Pope 1991 PM10 Utah and Salt Lake Valleys, UT, 0.000149 (0.000068) µg/m3 Mean monthly PM10
Respiratory 1985–1989 0.000139 (0.00026) µg/m3
< 2 Burnett et al. 2001 O3 Toronto, Canada, 1980–1994 0.00661 (0.0014) ppb Daily 1-hr maximum
moving average
Asthma 1–16 Friedman et al. 2001 PM10 Atlanta, GA, 2000 –0.0223 (0.044) µg/m3 3-day cumulative
PM10 –0.0511 (0.041) µg/m3 2-day cumulative
O3 0.00 (0.0049) ppb 3-day cumulative
O3 0.00 (0.0045) ppb 2-day cumulative
1–16 Sheppard et al. 1999 PM2.5 Seattle, WA, 1987–1994 0.00250 (0.00095) µg/m3 Daily average
CO 0.0528 (0.019) ppm Daily average
Emergency department 1–16 Friedman et al. 2001 PM10 Atlanta, GA, 2000 0.0337 (0.029) µg/m3 3-day cumulative
visits for asthma 0.0406 (0.026) µg/m3
PM10 0.00953 (0.027) µg/m3 2-day cumulative
0.0262 (0.024) µg/m3
O3 0.00673 (0.0033) ppb 3-day cumulative
0.00673 (0.0030) ppb
O3 0.00673 (0.0031) ppb 2-day cumulative
0.00673 (0.0028) ppb
1–16 Norris et al. 2000 PM10 Seattle, WA, 1995–1996 0.00892 (0.0035) µg/m3 24-hr average
CO 0.180 (0.064) ppm 24-hr average
SO2 0.0017 (0.0029) ppb Maximum daily 1-hr average
1–16 Norris et al. 1999 PM10 Seattle, WA, 1995–1996 0.0113 (0.0035) µg/m3 24-hr average
CO 0.159 (0.066) ppm
1–16 Schwartz et al. 1993 PM10 Seattle, WA, 1989–1990 0.00378 (0.0013) µg/m3 4-day average
1–16 White et al. 1994 PM10 Georgia, 1990 0.00198 (0.0042) µg/m3 1-hr maximummany investigators and can be used to assess
health impacts in the general form
where β = study-speciﬁc regression coefﬁcient
and ∆PC = change in pollutant concentration.
To allow comparability with previous studies,
we used estimated expected average changes in
annual air pollutant concentrations for the
entire United States on a national level
through 2010 based on our analysis of the U.S.
EPA 1990–2010 study (Farrow et al. 2001).
This led to estimated decreases in expected
concentrations of criteria air pollutants (point
estimates only): PM10 = 2.85 µg/m3, O3 =
1.34 ppb, CO = 1.68 ppm, NO2 = 9.4 ppb,
SO2 = 1.15 ppb (Farrow et al. 2001; U.S. EPA
1999a). These changes in concentration are the
estimated national average difference between
projected criteria air pollutant concentrations
in the year 2010 had the CAA not been in
place versus those with the CAA in place.
The present analysis was estimated for a
projected 2010 U.S. population ≤ 18 years old
of 76,461,986 and projected age distribution
of the population (U.S. Census Bureau 2002).
Baseline rates were obtained from U.S.
national sources (Adams and Marano 1995;
Martin et al. 2002; U.S. EPA 1999a) or from
individual studies (Gilliland et al. 2001; Ostro
et al. 2001; Ware et al. 1986). For analyses of
the health impacts, we combined regression
coefﬁcients from different studies of the same
health outcome using inverse variance weight-
ing methods to form a regression coefficient
speciﬁc to each end point and pollutant. Using
the inverse variance weighting method, we
weighted each study by its fractional contribu-
tion to the sum of the inverse variance of the
considered studies (per end point, per pollu-
tant). Results from multivariate regression
models were used when available. To deter-
mine the impacts of all pollutants for each
health outcome, we added together the impacts
caused by separate pollutants. Many of the
studies focused on children of a particular age
or ethnic group, so the results presented below
are for those speciﬁc groups. Pollutant-speciﬁc
health impact estimates have two significant
ﬁgures to assist with computation and to pre-
vent growth in rounding errors; however, they
are likely not significant to more than one
ﬁgure. If the lower bound includes a negative
number, estimates have not been truncated at 0,
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Table 2. Data from studies analyzing impacts on children’s health from nonhospitalization ailments (ages denote those examined in the present study).
End points Age (years) Reference Pollutant Location, year Risk coefﬁcient (SE) Exposure measure
Upper respiratory symptoms 10–12 Pope et al. 1991 PM10 Utah Valley, UT, 1989–1990 0.0036 (0.0015) µg/m3 Same day
Lower respiratory symptoms 7–14 Schwartz et al. 1994 PM2.5 6 U.S. cities, 1984–1988 0.0182 (0.0059) µg/m3 Daily average
Acute bronchitis 8–12 Dockery et al. 1996 PM2.1 24 U.S./Canadian cities, 1988–1990 0.0272 (0.017) µg/m3 Annual average
Respiratory illness 6–7 Hasselblad et al. 1992 NO2 Meta-analysis 0.0275 (0.013) ppb Annual change
Moderate or worse asthma 8–13 AA Ostro et al. 2001 PM10 Los Angeles, CA, 1993 0.00534 (0.0022) µg/m3 1-hr maximum
O3 0.00349 (0.0004) ppb 1-hr maximum
Shortness of breath, chest 8–13 AA Ostro et al. 2001 PM10 0.00231 (0.0017) µg/m3 24-hr average
tightness, or wheeze 0.00561 (0.0016) µg/m3
PM2.5 0.00194 (0.0008) µg/m3 12-hr average
0.000985 (0.0007) µg/m3
O3 –0.00155 (0.0008) ppb 1-hr maximum
–0.00181 (0.0008) ppb
NO2 0.00154 (0.0006) ppb 1-hr maximum
0.000591 (0.0006) ppb
6–9 Peters et al. 1999 PM10 Southern California, 1986–1990 0.00195 (0.0035) µg/m3 24-hr average
O3 0.00192 (0.0028) ppb 1-hr maximum
NO2 0.00345 (0.0048) ppb 24-hr average
6–9 Ware et al. 1986 PM10 6 cities, 1979–1980 0.0101 (0.0018) µg/m3 24-hr average
0.0103 (0.0046) µg/m3
0.0028 (0.0033) µg/m3
SO2 0.0091 (0.003) ppb 24-hr average
Shortness of breath 8–13 AA Ostro et al. 1995 PM10 Los Angeles, CA, 1992 0.00841 (0.0036) µg/m3 24-hr average
O3 0.00420 (0.0013) ppb 1-hr maximum
8–13 AA Ostro et al. 2001 PM10 Los Angeles, CA, 1993 0.00771 (0.0026) µg/m3 24-hr average
PM2.5 0.00257 (0.0013) µg/m3 12-hr average
O3 0.000249 (0.0011) ppb 1-hr maximum
NO2 0.00154 (0.0009) ppb 1-hr maximum
AA, African-American asthmatics.
Table 3. Data from studies analyzing children’s school absences and birth impacts (ages denote those examined in the present study).
End points Age (years) Reference Pollutant Location, year Risk coefﬁcient (SE) Exposure measure
School absences 9–10 Gilliland et al. 2001 PM10 Los Angeles area, 1996 –0.00440 (0.018) µg/m3 24-hr average
O3 0.0302 (0.014) ppb 8-hr average
NO2 0.0179 (0.032) ppb 24-hr average
9–10, 6–11 Ransom and Pope 1992 PM10 Utah Valley, UT, 1985–1986 to  0.0219 (0.0046) µg/m3 28-day average
1990–1991 0.0212 (0.0046) µg/m3
9–10, 6–11 Chen et al. 2000 PM10 Washoe County, NV, –0.0154 (0.0044) µg/m3 24-hr average
1996–1998
O3 0.0132 (0.0049) ppb 1-hr maximuma
CO 0.193 (0.072) ppm 1-hr maximum
LBW Singleton, Maisonet et al. 2001 PM10 U.S. cities,b 1994–1996 –0.00408 (0.0047) µg/m3 Average for 3rd month
ﬁrst birth CO 0.270 (0.11) ppm of pregnancy
SO2 0.000995 (0.0085) ppb
Ritz and Yu 1999 CO Southern California, 1989–1993 0.0289 (0.029) ppm Average last trimester
Ventricular Singleton Ritz et al. 2002 O3 Southern California, 1987–1993 0.122 (0.15) ppb Average for 2nd month
septal defect CO 0.285 (0.15) ppm of pregnancy
aPreceding 14 days. bBoston and Springﬁeld, MA; Hartford, CT; Philadelphia and Pittsburgh, PA; and Washington, DC.to provide a sense of the uncertainty associated
with results. We used available data for each
pollutant and health effect considered in a
one-dimensional 10,000-run Monte Carlo
simulation to determine the health impacts
(Burmaster and Anderson 1994; Thompson et
al. 1992). Monte Carlo simulation is a statisti-
cal technique that allows for the propagation of
uncertainty in an analysis. Use of this tech-
nique allows us to use information about the
uncertainty around the point estimate of effect
reported in the original, peer-reviewed studies.
Analyses were conducted in Microsoft Excel
(Microsoft Corp., Redmond, WA) and used
Decisioneering Crystal Ball (Decisioneering
Inc. 2000), an Excel add-on that allows an
analyst to perform Monte Carlo simulations.
To consider the potential economic
impacts, beneﬁts were the present value bene-
ﬁts of considered health effects as estimated in
published studies. Estimates of the reduced
number of cases can be combined with existing
economic valuation data to determine the ben-
efits associated with reductions in these ill-
nesses. We determined mortality estimates
using existing recommendations for the value
of a statistical life at $4.8 (SD = 3.2) million in
1990 US$ (U.S. EPA 1999a). Not all health
end points considered have available valuation
data that are specific for children. Limited
child-speciﬁc information on the present value
of asthma hospitalizations, emergency depart-
ment visits for asthma, school absences, and
LBW is available (Hall et al. 2002; Smith et al.
1997; U.S. EPA 1999b; Weiss et al. 1992).
Smith et al. (1997) estimated a value of $4,900
(SD = 1,300) in 1990 US$ for each asthma
hospitalization, $220 (SD = 42) per emergency
department visit, and $42 (SD = 8) per school
absence. Alternatively, point estimates of values
associated with select health end points are
available. U.S. EPA (1999b) estimates a value
of $18,000 (1990 US$) for all medical costs
associated with LBW in infancy, an average
annual cost of $34 per patient for emergency
department visits, and $2,000 per asthma hos-
pitalization. Yet other alternative data from
Weiss et al. (1992) for children ≤ 17 years old
value each case at $2,200 (1990 US$) per
asthma hospitalization, $150 per emergency
department visit, and $100 per school absence.
Unlike the latter two studies, in Smith et al.
(1997) CIs are used to represent uncertainty,
but no information is presented that allows
child-speciﬁc values to be estimated. Estimates
from Weiss et al. (1992) and estimates of aver-
age hospitalization costs from U.S. EPA
(1999b) were speciﬁc for children < 18 years
old; however, only point estimates were pre-
sented. Although there are moderate differ-
ences in the estimates presented by the three
sources, no one source can be considered
preferable to the others. We adjusted valuation
estimates from these studies to 1990 US$ by
using the Consumer Price Index Medical Care
(U.S. Department of Labor Bureau of Labor
Statistics 2002) to facilitate comparison with
prior analyses, particularly that of U.S. EPA
(1999a), which reports values in 1990 US$.
Results
In this study, we analyzed children’s health
impacts from changes in ambient concentra-
tions of the criteria air pollutants (excluding
lead) due to the CAA from 1990 through
2010 (Figure 1). Reductions in PM10 in the
year 2010 were estimated to lead to a median
of 160 (5th–95th percentiles; 90% CI,
45–270) fewer expected cases of postneonatal
mortality (from 1 month to 1 year of birth);
3,000 (500–6,000) fewer respiratory hospitali-
zations in children 0–2 years of age, or 10,000
(1,000–20,000) fewer in children 0–5 years of
age; and 1,300 (480–6,600) fewer emergency
department visits in children 1–16 years of age
(Figure 1, Table 4). Approximately 2.5 (–1.8
to 3.5) million school absences may also be
avoided by children 6–11 years old in the
United States.
Small reductions in ambient O3 concentra-
tions may lead to 700 (400–1,000) fewer respi-
ratory hospitalizations in children ages 0–2 and
1,600 (220, 3,000) fewer emergency depart-
ment visits for asthma in children ages 1–16,
or 750,000 (470,000–1,000,000) fewer school
absences in children ages 6–11 (Figure 1, Table
4). Reductions in CO concentrations may lead
to 9,400 (4,200–19,000) fewer asthma hospi-
talizations or 35,000 (8,800–66,000) emer-
gency department visits in children ages 1–16
years. NO2 reductions may lead to 2.2 (–8.4 to
7.9) million fewer school absences in children
ages 9–10.
Combining the pollutant-specific esti-
mates, the speciﬁed changes in criteria air pol-
lutant concentrations would lead to a total of
10,000 (4,000–20,000) averted asthma hospi-
talizations and 40,000 (10,000–70,000) fewer
emergency department visits in children ages
1–16. Approximately 20 (10–20) million fewer
school absences in children ages 6–11 and
10,000 (–20,000 to 70,000) averted LBW
infants may also be expected (Table 4).
Estimated reductions in air pollution con-
centrations in 2010 could lead to reduced post-
neonatal mortality with estimated beneﬁts of
$590 ($150–1,300) million (1990 US$).
Because we are aware of only three sources of
valuation data, we report valuation results sepa-
rately using each of the three studies (all 1990
US$). Using estimates from Smith et al.
(1997), benefits of $46 ($17–84) million in
asthma hospitalizations, $5 ($2–11) million in
emergency department visits for asthma, and
$700 ($400–1,000) million in school absences
are estimated (Table 5). Using estimates from
U.S. EPA (1999b) results in benefits of $20
($6–42) million for asthma hospitalizations,
$1.3 ($0.3–3) million for emergency depart-
ment visits, and $230 (–$500 to 1,400) mil-
lion for LBW costs during infancy (Table 5).
Using estimates from Weiss et al. (1992) for
children < 17 years old leads to beneﬁts of $22
($7–47) million in asthma hospitalizations,
$5.8 ($1.3–12) million for emergency depart-
ment visits, and $1.8 ($0.75–2.4) billion for
school absences in children 6–11 years of age
(Table 5).
Discussion
Given the currently available health literature
on children’s health effects associated with the
criteria air pollutants (excluding lead) and the
limited literature on the valuation of chil-
dren’s health, this analysis should be consid-
ered as a starting point and as identifying key
research needs for examining a unique and
susceptible population in beneﬁt–cost or cost-
effectiveness analyses of environmental poli-
cies. When additional information on health
effects and detailed economic valuation data
for children are available, the data can be
combined and used in analyses of environ-
mental policies. The results of the present
analysis are not intended to and cannot pro-
vide absolute estimates of the beneﬁts to chil-
dren associated with decreases in ambient
criteria air pollutant levels, but can provide
information about the importance of chil-
dren’s health effects in aggregate studies based
on an assessment of order of magnitude or
ranges of expected health beneﬁts.
The magnitude of omitting children’s
health impacts can be seen when comparing
the mean impact results here with mean
U.S. EPA (1999a) results. Inclusion of child-
specific data on asthma hospitalizations,
emergency department visits for asthma,
school absences, and LBW could be expected
to add between $1 and $2 billion (depending
on source of valuation estimates) to the
$8 billion (1990 US$) in mean health bene-
fits from decreased morbidity currently esti-
mated by U.S. EPA (1999a) for the U.S.
population. Consideration of postneonatal
mortality would add $600 million to the pre-
sent mean estimate of $100 billion resulting
from decreases in adult mortality (U.S. EPA
1999a). Decreases in adult mortality were the
key driver in prior analyses of benefits and
costs. Although the benefits to infants are a
small percentage (< 1%) of the estimated
benefits to adults, benefits were estimated
for adults ≥ 30 years old, whereas benefits
estimated here are for infants only between
1 month and 1 year of age. Future research
examining the susceptibility of children and
young adults is needed.
Availability of data for additional children’s
health end points and consideration of other
metrics (e.g., life-years) may be expected to
increase estimates of children’s health beneﬁts.
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using cost of illness methods and are consid-
ered lower bounds of the estimate (Krupnick
2003; U.S. EPA 1999b). Our current analysis
presents results only for speciﬁc age or ethnic
groups and does not extrapolate findings
to the total population of U.S. children.
Extrapolation to all children would be expected
to lead to an increase in the number of cases
averted. Thus, estimated health benefits in
this analysis may be considered conservative.
The “value of a statistical life” method has
long been a subject of contention (Viscusi
1993). Recent attention has focused on using
life-years lost or valuing a life without using
an age adjustment. To provide comparisons
with the U.S. EPA’s estimates of the beneﬁts
and costs of the CAA, each estimated prema-
ture death of a child was valued at the same
value as an adult. These approaches have
recently been afﬁrmed by the federal govern-
ment in the face of opposition to the “senior
discount” implicit in valuing life-years saved
(Graham 2003; Whitman 2003).
The above estimates for the child-speciﬁc
impacts of the CAA are comparable with
recent studies. Via the modiﬁed Delphi tech-
nique (an expert elicitation method), 30% of
acute exacerbations of pediatric asthma were
estimated to be environmentally related, for
an estimated $2 billion (1997 US$) per year
in environmentally attributable costs of pedi-
atric asthma in the United States (Landrigan
et al. 2002). U.S. EPA (1999a) estimated the
beneﬁts associated with 950,000 upper respi-
ratory symptoms, 520,000 lower respiratory
symptoms, and 330,000 respiratory illness
cases to reach $19 million, $6 million, and
$6 million (1990 US$) per year, respectively.
In the present analysis, benefits resulting
from reduced numbers of LBW infants arose
from the first year of birth only, but LBW
may also have lifelong effects on health and
productivity. Lifetime medical costs due to
LBW of $436,000 (1996 US$, undiscounted)
have been estimated (U.S. EPA 1999b). Use
of lifetime estimates rather than those from
the first year of birth alone would lead to
increased estimates of health benefits. The
benefits of reduced birth defects were not
explicitly calculated in the present analysis
because of mismatches in health and eco-
nomic end points. However, given available
economic data on other types of cardiac
defects, additional beneﬁts in the hundreds of
millions could be inferred.
Many assumptions were included in the
present analysis. Prior analyses have focused
on geographically detailed estimates of expo-
sures, whereas we did not include modeling of
ambient exposures, regional variation, or
human activity patterns affecting exposure.
Average nationwide ambient concentrations
were estimated from U.S. EPA (1999a).
Although this approximation neglects the sea-
sonal and regional variation of ambient air
pollution, our purpose was to generate a pre-
liminary estimate of the impacts in children
in the entire United States over time. The
extent to which air pollutants are merely a
marker for some other compound will also
affect the ﬁndings of this analysis. Because of
the complex interplay of copollutants found
in the United States, it may be difﬁcult to dis-
tinguish the role of each pollutant.
The results of this analysis depend on the
available information in the peer-reviewed lit-
erature. Some of the studies used in the present
analysis (e.g., Woodruff et al. 1997) were not
included in the U.S. EPA (1999a) analysis,
reportedly because of lack of confidence in
the new end point of postneonatal mortality.
Child-speciﬁc associations are the focus of this
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Figure 1. Estimated reductions in 2010 in health end points considered for speciﬁc age groups (years), by
pollutant: 50th percentile presented with error bars indicating 5th–95th percentile.
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Table 4. Estimated reduced numbers of select health end points by pollutant.
Postneonatal Asthma Emergency
mortalitya hospitalizationsa department visitsa School absencesa,b LBWa
Pollutant (1 month–1 year) (1–16 years) (1–16 years) (9–10 years) (6–11 years) (singletons)
PM10 160 (45–270) 430 (150–700) 1,300 (480–6,600) 0.85 (–0.67 to 1.2) 2.5 (–1.8 to 3.5) –3,300 (–13,000 to 7,200)
O3 — –10 (–1,300 to 1,300) 1,600 (220–3,000) 0.26 (0.16–0.37) 0.75 (0.47–1.0) —
CO — 9,400 (4,200–19,000) 35,000 (8,800–66,000) 4.6 (3.0–6.4) 14 (8.5–19) 16,000 (–13,000 to 69,000)
NO2 —— —2.2 (–8.4 to 7.9) — —
SO2 ——380 (–920 to 1,600) — — 300 (–6,000 to 6,500)
Totalc — 10,000 (4,000–20,000) 40,000 (10,000–70,000) 8.0 (–2.0 to 10) 20 (10–20) 10,000 (–20,000 to 70,000)
—, data unavailable. Note lack of available child-speciﬁc data for some end points and age groups.
a50th percentile [5th–95th percentile (90% CI)]. bIn millions. cPollutant-speciﬁc estimates have two signiﬁcant ﬁgures to assist with computation; totals may not add due to rounding.
Table 5. Values per case from the literature and estimated beneﬁts associated with age-group–speciﬁc reductions in select health end points (1990 US$).
Value per case a Estimated beneﬁts (in millions)b
Smith et al. U.S. EPAc Weiss et al. Smith et al. U.S. EPA Weiss et al.
End point (1997) (1999a, 1999b) (1992) (1997) (1999a, 1999b) (1992)
Postneonatal mortality — 4.8 ± 3.2 million — — 590 (150–1,300) —
Asthma hospitalizations 4,900 ± 1,300 2,000 2,200 46 (17–84) 20 (6–42) 22 (7–47)
Emergency department visits 220 ± 42 34d 150 5 (2–11) 1.3 (0.3–3) 5.8 (1.3–12)
School absencee 42 ± 8 — 100 700 (400–1, 000) — 1,800 (750–2,400)
LBW — 18,000 — — 230 (–500 to 1,400) —
—, data unavailable.
aMean ± SE. U.S. EPA (1999b) and Weiss et al. (1992) are point estimates only. bMonetized value based on each study. 50th percentile [5th–95th percentile (90% CI)]. cMortality estimates
from U.S. EPA (1999a); morbidity estimates from U.S. EPA (1999b). dAnnual average cost per patient. eEstimate of cases averted in children 6–11 years old.preliminary study, and all available evidence
was used. Any choices or assumptions made by
the original investigators (e.g., choice of expo-
sure–response function, adjusting for key vari-
ables) are implicitly included in this analysis.
Differences in study design, regional air pollu-
tant characteristics, and sources of data used
may affect the comparability of studies but
should not signiﬁcantly affect their aggregate
interpretation. The results of this analysis may
be affected by results of the effort to reanalyze
results of several existing studies because of
software errors (Health Effects Institute 2002).
However, the impact on the present analysis is
not expected to be significant because few
studies used the affected statistical procedure.
Future quantitative analyses of children’s
health beneﬁts may wish to evaluate effects sep-
arately for different ages in order to use other
metrics such as years of life lost or quality-
adjusted life-years (Fabian 1994). Increased
data from cohort studies will allow estimation
of life-years for use in these measures (National
Research Council 2002). An age-speciﬁc analy-
sis may better reﬂect higher-risk age groups. For
example, Ransom and Pope (1992) reported
absences by grade, with a higher effect seen in
the younger grades. Similarly, Burnett et al.
(1994) found that infants ≤ 1 year old had sig-
nificantly more respiratory hospitalizations
(15% of admissions) associated with air pollu-
tion than did the middle-aged and elderly
groups (4%) examined.
For many of the children’s health effects
considered, the paucity of existing health
effects data and economic data represents an
opportunity for health researchers to present
informative end points and data for economic
analyses. Similarly, it presents an opportunity
for health economists to provide key data for
a susceptible population and an opportunity
for increased collaboration between health
risk assessors and economists for improved
environmental health decision making. To
take advantage of these opportunities, agen-
cies need to consider funding priorities in
children’s health and health economics.
The estimates of health beneﬁts are conser-
vative. Estimates of the number of cases
averted are presented only for specific age
groups. Some health effects were unable to be
included in the analysis. Estimates of the bene-
fits are also low because we present data for
only a subset of health effects considered (those
with economic valuation information available
on children’s health effects). Cost-of-illness
estimates do not include pain and suffering,
altruism, or lost leisure time. However, the
results of this analysis suggest that air pollution
imposes a signiﬁcant burden on U.S. children
and have also allowed us to identify signiﬁcant
data gaps that impede our understanding of
the full beneﬁts of air pollutant reductions for
children’s health.
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